Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren E Regelmann

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 22, 2016
Pulmonary function tests correlated with thoracic volumes in adolescent idiopathic scoliosisCharles Gerald T Ledonio, Benjamin E Rosenstein, Charles E Johnston, et al.
Pediatric Pulmonology|October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology|August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisJeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology|May 1, 2007
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung functionClement L Ren, Wayne J Morgan, Michael W Konstan, et al.
Respiratory Care|April 21, 2017
Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic FibrosisChristina L Mikesell, Robert R Kempainen, Theresa A Laguna, et al.
Pediatric Pulmonology|September 6, 2012
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptomsWarren E Regelmann, Michael S Schechter, Jeffrey S Wagener, et al.
Pediatric Pulmonology|December 23, 2014
Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care siteMichael S Schechter, Warren E Regelmann, Gregory S Sawicki, et al.
The Lancet. Respiratory Medicine|January 25, 2016
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm studyJane C Davies, Steve Cunningham, William T Harris, et al.
Pediatric Pulmonology|April 20, 2004
Pulmonary exacerbations in cystic fibrosisHarvey R Rabin, Steven M Butler, Mary Ellen B Wohl, et al.
Open Forum Infectious Diseases|January 19, 2026
An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis ExacerbationsHollyAnn R Jacobs, Kristyn A Packer, Luis G Vargas Buonfiglio, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 22, 2016
Pulmonary function tests correlated with thoracic volumes in adolescent idiopathic scoliosisCharles Gerald T Ledonio, Benjamin E Rosenstein, Charles E Johnston, et al.
Pediatric Pulmonology|October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosisGregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology|August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisJeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology|May 1, 2007
Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung functionClement L Ren, Wayne J Morgan, Michael W Konstan, et al.
Respiratory Care|April 21, 2017
Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic FibrosisChristina L Mikesell, Robert R Kempainen, Theresa A Laguna, et al.
Pediatric Pulmonology|September 6, 2012
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptomsWarren E Regelmann, Michael S Schechter, Jeffrey S Wagener, et al.
Pediatric Pulmonology|December 23, 2014
Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care siteMichael S Schechter, Warren E Regelmann, Gregory S Sawicki, et al.
The Lancet. Respiratory Medicine|January 25, 2016
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm studyJane C Davies, Steve Cunningham, William T Harris, et al.
Pediatric Pulmonology|April 20, 2004
Pulmonary exacerbations in cystic fibrosisHarvey R Rabin, Steven M Butler, Mary Ellen B Wohl, et al.
Open Forum Infectious Diseases|January 19, 2026
An Observational Cohort Study of Targeted Antibiotic Treatments of Cystic Fibrosis ExacerbationsHollyAnn R Jacobs, Kristyn A Packer, Luis G Vargas Buonfiglio, et al.
Pageof 3